Yahoo Web Search

Search results

1. • ... on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating Motixafortide in...

     WKRN Nashville· 5 days ago

     ...BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that an abstract including new data from the single-arm pilot phase of the investigator-initiated, randomized CheMo4METPANC Phase 2 combination clinical trial was...

2. • 

     Certara moves its corporate headquarters to the Main Line - Philadelphia Business Journal

     The Business Journals· 6 days ago

     Certara, a technology company that specializes in biosimulation software used to accelerate drug...

3. • 

     Better Buy: Inovio Pharmaceuticals vs. Novavax

     Motley Fool via Yahoo Finance· 6 days ago

     RRP can cause difficulty performing otherwise routine tasks, such as breathing, swallowing, or speaking. Inovio estimates an annual prevalence of 14,000...

4. • Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024

     FOX 23 News Albany· 5 days ago

     ...of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (#ASCO24), which is taking place virtually and in-person...include an oral presentation on biomarker analyses from the pivotal Phase 3...

5. • OncoHost to Present Poster Demonstrating PROphet®'s Application in Multiple Cancer Indications at...

     FOX21 Colorado Springs· 5 days ago

     OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced that it has been accepted for a poster presentation at the upcoming ...

6. • StemCyte Renews Contract with the California State Umbilical Cord Blood Collection Program

     CBS 47 Fresno· 5 days ago

     StemCyte, a leader in cord blood-based regenerative therapeutics in Southern California, is excited to announce the renewal of its partnership with the California State Umbilical Cord Blood ...

7. • 

     Exact Sciences files second patent infringement case against St. Louis competitor Geneoscopy - St....

     The Business Journals· 6 days ago

     Exact Sciences Corp., the Madison, Wisconsin, developer of the stool-based Cologuard colorectal...

8. • AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review

     ETF DAILY NEWS· 4 days ago

     AbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...

9. • CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development...

     Morningstar· 12 hours ago

     TÜBINGEN, GERMANY AND BOSTON, MA / ACCESSWIRE / May 28, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based ...

10. • Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and...

      WFRV 5 Green Bay· 4 days ago

      Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the presentation of seven studies at the American Society of